RecruitingEarly Phase 1NCT06706765

Group Telehealth Behavioral Cough Suppression Therapy

Group Telehealth Behavioral Cough Suppression Therapy Pilot Study

Sponsor

University of Montana

Enrollment

60 participants

Start Date

Mar 22, 2024

Study Type

INTERVENTIONAL

Conditions

Refractory Chronic Cough

Summary

The purpose of this study is to investigate the effectiveness of behavioral cough suppression therapy (BCST) in managing refractory chronic cough (RCC) within a group telehealth setting. RCC is a cough that has lasted at least 8 weeks and has not resolved with standard medical treatment. BCST is a research-based treatment provided by specialty-trained speech-language pathologists (SLPs) for patients with RCC. Although the treatment works very well for a large proportion of patients in a standard one-on-one format, there are a limited number of SLPs available to provide this treatment and patients living in rural areas do not typically have access to an SLP trained in BCST. If BCST can effectively be delivered in a group telehealth model, it would significantly improve accessibility to the treatment.

Eligibility

Min Age: 18 Years

Inclusion Criteria7

At least 18 years old
Predominantly dry cough for at least 8 weeks
Evaluated and treated by at least one physician for cough
Obtained a chest X-ray or chest CT scan specifically related to the cough with unremarkable results
Access to a computer or tablet that includes a camera and able to use the device independently
Reliable internet access
Willing to agree to maintain confidentiality of personal information (including names) related to others in the study

Exclusion Criteria9

Under age 18
Coughing up blood
Current smoker of any substance
History of smoking or 10 or more years
Diagnosed with a chronic lung condition (e.g., COPD, emphysema, lung cancer, idiopathic pulmonary fibrosis, chronic bronchitis, asthma)? (NOTE: If a patient has been told their cough may be (or is likely) due to asthma but they have not had any formal lung testing and asthma treatments have not helped your cough, we don't consider this a formal asthma diagnosis and will not exclude them from the study.)
Diagnosed currently or in the past with head and neck cancer (i.e., cancer of the mouth, nose, or throat).
Complaints of swallowing difficulty
Taking any of the following medications, which have a known side effect of cough: Benzapril (Lotensin), Captopril (Capoten), Enalapril/Enalaprilat (Vasotec oral and injectable), Fosinopril (Monopril), Lisinopril (Zestril and Prinivil), Moexipril (Univasc), Perindopril (Aceon), Quinapril (Accupril), Ramipril (Altace), and Trandolapril (Mavik)
Prior BCST treatment with an SLP or respiratory therapist

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.